0001834150-20-000002.txt : 20201215
0001834150-20-000002.hdr.sgml : 20201215
20201215143328
ACCESSION NUMBER: 0001834150-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
EFFECTIVENESS DATE: 20201215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Decheng Capital Global Life Sciences Fund IV, L.P.
CENTRAL INDEX KEY: 0001834150
IRS NUMBER: 981568621
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-383255
FILM NUMBER: 201389268
BUSINESS ADDRESS:
STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED
STREET 2: UGLAND HOUSE, P.O. BOX 309
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 345-949-8066
MAIL ADDRESS:
STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED
STREET 2: UGLAND HOUSE, P.O. BOX 309
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
D
1
primary_doc.xml
X0708
D
LIVE
0001834150
Decheng Capital Global Life Sciences Fund IV, L.P.
C/O MAPLES CORPORATE SERVICES LIMITED
UGLAND HOUSE, P.O. BOX 309
GRAND CAYMAN
E9
CAYMAN ISLANDS
KY1-1104
345-949-8066
CAYMAN ISLANDS
None
None
Other
Cayman Islands exempted limited partnership
true
2020
N/A
N/A
Decheng Capital Management IV (Cayman), LLC
c/o Maples Corporate Services Limited
Ugland House, P.O. Box 309
Grand Cayman
E9
CAYMAN ISLANDS
KY1-1104
Promoter
General Partner of the Issuer
Xiangmin
Cui
c/o Maples Corporate Services Limited
Ugland House, P.O. Box 309
Grand Cayman
E9
CAYMAN ISLANDS
KY1-1104
Promoter
Manager of the General Partner of the Issuer
Fengying
Yu
c/o Maples Corporate Services Limited
Ugland House, P.O. Box 309
Grand Cayman
E9
CAYMAN ISLANDS
KY1-1104
Promoter
Manager of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
false
true
false
true
false
0
650000000
0
650000000
false
0
0
0
0
The Issuer's General Partner (or its designee) is entitled to the payment of a management fee payable by the Issuer.
false
Decheng Capital Global Life Sciences Fund IV, L.P.
/s/ Xiangmin Cui
Xiangmin Cui
Manager of the General Partner of the Issuer
2020-12-15